Sep 24, 2026 06:00AM
Sep 24, 2026 06:00AM
Sep 1, 2026 04:39PM
Aug 7, 2026 04:01PM
Jul 15, 2026 08:00AM
Jul 15, 2026 08:00AM
May 15, 2026 08:00AM aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update
May 11, 2026 04:01PM
May 11, 2026 04:01PM
Mar 6, 2026 12:19PM
Mar 6, 2026 08:31AM
Mar 5, 2026 04:01PM
Feb 3, 2026 08:01AM
Feb 3, 2026 08:00AM aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis
Nov 6, 2025 04:01PM
Sep 15, 2025 12:55PM
Sep 15, 2025 12:23PM
Sep 15, 2025 11:57AM
Sep 15, 2025 10:58AM
Sep 15, 2025 07:30AM
Sep 15, 2025 07:30AM aTyr Pharma Announces Topline Results from Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis
Jun 4, 2025 08:03AM
Jun 4, 2025 08:00AM
Apr 23, 2025 09:43AM
Mar 14, 2025 06:51AM
Mar 14, 2025 06:40AM
Mar 13, 2025 04:01PM
Dec 21, 2024 10:00AM RBC report: Biotech faces both uncertainty and growth opportunities in 2025
Nov 19, 2024 08:07AM
Oct 29, 2024 07:27AM
Oct 21, 2024 07:35AM

331,932 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All